MOLECULAR ANALYSIS OF HUNTINGTON’S DISEASE IN THE REPUBLIC OF MACEDONIA
Koceva S1,2, Dimovski AJ1, Plaseska-Karanfiska D1, Stefanovska A-M1, Vlaski-Jekic S3, Efremov GD1,*
*Corresponding Author: Professor Dr. Georgi D. Efremov, Macedonian Academy of Sciences and Arts, Research Center for Genetic Engineering and Biotechnology, Aven Krste Misirkov 2, POB 428, 1000 Skopje, Republic of Macedonia; Tel: +3892-120253; Fax: +3892-115434; E-mail: gde@manu.edu
page: 47

MATERIALS AND METHODS

Patients. Ten families from the Republic of Macedonia were included in the analysis of the IT15 gene. Seven patients were referred for diagnostic testing due to the presence of clinical signs consistent with HD, while three individuals required predictive testing due to the presence of the disease in the family. The data on age, gender, family history and type of referral of the patients is summarized in Table 1.

      Methods. DNA was isolated from leukocytes using the proteinase K/SDS digestion-phenol/chloroform extraction-ethanol precipitation method, routinely used in our laboratory [9]. The conventional analyses consisted of polymerase chain reaction (PCR) analysis of exon 1 of the IT15 gene, denaturing polyacrylamide gel electrophoresis (PAGE) of the resulting fragments, transfer to a nylon membrane, hybridization with a digoxigenin labeled internal probe and visualization by autoradiography [10,11]. Polymerase chain reaction amplification was performed in a reaction volume of 25 mL using 50 ng of genomic DNA, 25 pmol of each primer (direct: 5'-ATG AAG GCC TTC GAG TCC CTC AAG TCC TTC-3' and reverse: 5'-AAA CTC ACG GTC GGT GCA GCG GCT CCT CAG-3'), 10 mM Tris (pH 8.3), 5 mM KCl, 2 mM MgCl2, 200 mM (each) dNTPs, 10% dimethylsulfoxide and 2.5 U of Taq polymerase (AmpliTaq Gold; Applied BioSystems, Palo Alto, CA, USA). After initial heating at 94EC for 10 min, the reaction mix was subjected to 40 cycles of amplification, each consisting of incubation for 1 min at 94EC, 1 min at 60EC and 2 min at 72EC. Two mL of each PCR were diluted with two volumes of 95% formamide loading dye and heat denatured for 2 min at 95EC. The products were resolved on a 6% denaturing polyacrylamide gel (40 x 20 cm x 0.4 mm) containing 6 M urea and 32% formamide. The electrophoresis was run at 70 W constant power for 2 hours and the fragments were transferred to a positively charged nylon membrane (Hybond+; Amersham BioSciences UK Ltd., Little Chalfont, Buckinghamshire, England). The membranes were hybridized with a non radioactively labeled oligonucleotide probe (5’-CAG CAG CAG CAG CAG CG-3’) and detected by chemi­luminescence. Details for non radioactive labeling of oli­gonucleotide probes, allele specific hybridization and che­miluminiscent detection are as given previously [10,11]. A representative autoradioagram showing the results obtained using the PCR-PAGE method is given in Fig. 1. The results obtained with the non radioactive PCR-PAGE method were compared with the results obtained with automated fluorescent PCR/ capillary electrophoresis analysis using the ABI PRISM™ 310 Genetic Analyzer (Applied BioSystems). In this assay, PCR was performed under the same conditions as described above, the only difference being that the direct primer was labeled at the 5’-end with FAM fluorescent dye. Following amplification, 1-2 mL of the PCR reaction were mixed with 25 mL of deionized formamide and 1 mL of ROX-labeled size marker (Applied BioSystems), denatured for 3 min at 95EC and run on the ABI PRISM™ 310 Genetic Analyzer (Applied BioSystems). The results obtained were analyzed using the GeneScan Software II (Applied BioSystems). Electrophoretograms showing the detection of expanded CAG repeats in exon 1 of the HD gene in two HD patients are shown in Fig. 2.

 

Table 1. Basic data of individuals included in the molecular analysis of Huntington's disease in the Republic of Macedonia

 

Patient

Sex-Age

Family
History

Referral

Allele 1

Allele 2

M.A.

M-54

None

D

18

43

J.N.

M-48

Yes

D

19

46

I.A.

M-52

Yes

D

15

44

X.P.

F-50

None

D

17

47

I.T.

F-52

Yes

D

19

42

R.M.

F-54

Yes

D

26

42

G.D.

M-12

Yes

D

17

22

S.S.

F-30

Yes

P

17

42

J.M.

F-32

Yes

P

26

16

N.M.

F-39

Yes

P

17

46

D: diagnosis; P: predictive testing

 

Figure 1. The PCR-PAGE analysis of (CAG)n repeat in exon 1 of the HD gene showing the detection of expanded alleles in three subjects (lanes 1-3).

 




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006